ctrl K

Vaxcyte Inc. (PCVX)

NASDAQ: PCVX · Real-Time Price · USD

35.32

-0.52 (-1.45%)

At close: May 01, 2025, 3:59 PM

35.24

-0.23%

After-hours: May 01, 2025, 07:05 PM EDT

Vaxcyte Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	75M	9.2M	1.8M	1.41M	1.23M	1.04M	n/a
Gross Profit	n/a	-75M	-9.2M	-1.8M	-1.41M	-1.23M	-1.04M	n/a
Operating Income	-569.55M	-468.04M	-232.26M	-103.67M	-89.58M	-54.15M	-35.53M	-17.83M
Interest Income	109.99M	62.91M	8.36M	344K	244K	632K	903K	164K
Pretax Income	-463.93M	-402.27M	-223.49M	-100.08M	-89.22M	-50.27M	-29.48M	-17.24M
Net Income	-463.93M	-402.27M	-239.64M	-100.08M	-87.82M	-53.5M	-29.48M	-17.24M
Selling & General & Admin	92.9M	60.7M	39.81M	25.26M	16.02M	8.55M	5.39M	5.05M
Research & Development	476.64M	332.34M	169.45M	78.41M	73.56M	45.61M	30.14M	12.79M
Other Expenses	n/a	n/a	-1.93M	-1.58M	-2.48M	-237K	5.18M	n/a
Operating Expenses	569.55M	468.04M	207.33M	102.08M	87.1M	53.92M	35.53M	17.4M
Interest Expense	n/a	n/a	2K	7K	7K	40K	75K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	468.04M	207.33M	102.08M	87.1M	53.92M	35.53M	17.4M
Income Tax Expense	n/a	n/a	16.16M	7K	-1.4M	3.23M	6.12M	n/a
Shares Outstanding (Basic)	122M	97.16M	64.88M	51.92M	29.55M	3.79M	3.63M	3.56M
Shares Outstanding (Diluted)	122M	97.16M	64.88M	51.92M	29.55M	3.8M	3.63M	3.57M
EPS (Basic)	-3.8	-4.14	-3.69	-1.93	-2.97	-14.1	-8.12	-4.84
EPS (Diluted)	-3.8	-4.14	-3.69	-1.93	-2.97	-14.1	-8.12	-4.83
EBITDA	-569.55M	-464.88M	-214.29M	-98.28M	-87.81M	-49M	-28.37M	-17.21M
EBIT	n/a	-468.04M	-223.49M	-100.08M	-89.21M	-50.23M	-29.41M	-17.83M
Depreciation & Amortization	n/a	3.16M	9.2M	1.8M	1.41M	1.23M	1.04M	625K